Your browser doesn't support javascript.
loading
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies.
Osmanska, Joanna; Brooksbank, Katriona; Docherty, Kieran F; Robertson, Stacy; Wetherall, Kirsty; McConnachie, Alex; Hu, Jerry; Gardner, Roy S; Clark, Andrew L; Squire, Iain B; Kalra, Paul R; Jhund, Pardeep S; Muntendam, Pieter; McMurray, John J V; Petrie, Mark C; Campbell, Ross T.
Affiliation
  • Osmanska J; School of Cardiovascular and Metabolic Health, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.
  • Brooksbank K; Department of Cardiology, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK.
  • Docherty KF; School of Cardiovascular and Metabolic Health, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.
  • Robertson S; School of Cardiovascular and Metabolic Health, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.
  • Wetherall K; Department of Cardiology, Queen Elizabeth University Hospital, Glasgow G51 4TF, UK.
  • McConnachie A; School of Cardiovascular and Metabolic Health, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.
  • Hu J; Robertson Centre for Biostatistics, University of Glasgow G12 8TB, UK.
  • Gardner RS; Robertson Centre for Biostatistics, University of Glasgow G12 8TB, UK.
  • Clark AL; Allucent, Durham, NC 27713, USA.
  • Squire IB; Scottish National Advanced Heart Failure Service, Golden Jubilee National Hospital, Glasgow G81 4DY, UK.
  • Kalra PR; Department of Academic Cardiology, Hull University Teaching Hospital NHS Trust, Hull GU16 5JQ, UK.
  • Jhund PS; Department of Cardiovascular Sciences, University of Leicester, and NIHR Cardiovascular Biomedical Research Centre, Glenfield Hospital, Leicester LE3 9QP, UK.
  • Muntendam P; Department of Cardiology, Queen Alexandra Hospital, Portsmouth Hospitals University NHS Trust, Portsmouth PO6 3LY, UK.
  • McMurray JJV; School of Cardiovascular and Metabolic Health, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.
  • Petrie MC; SQ Innovation Inc., Burlington, MA 01803, USA.
  • Campbell RT; School of Cardiovascular and Metabolic Health, British Heart Foundation Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow G12 8TA, UK.
Eur Heart J Cardiovasc Pharmacother ; 10(1): 35-44, 2024 Jan 05.
Article in En | MEDLINE | ID: mdl-37804170
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Furosemide / Heart Failure Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2024 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Furosemide / Heart Failure Limits: Humans Language: En Journal: Eur Heart J Cardiovasc Pharmacother Year: 2024 Document type: Article Affiliation country: United kingdom